- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00506584
Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants
A Randomized Study of Human Milk-Based Versus Bovine-based Nutrition for Very Low Birth Weight Pre-Term Infants
Study Overview
Status
Conditions
Intervention / Treatment
- Dietary supplement: Pasteurized human milk and pasteurized human milk fortifier
- Dietary supplement: Pasteurized human milk and pasteurized human milk fortifier
- Dietary supplement: Pasteurized human milk and pasteurized human milk fortifier
- Dietary supplement: Human milk fortifier (bovine-based), pre-term formula
- Dietary supplement: Pre-term/term formula
Detailed Description
The goal of this study is to evaluate the short-term effect (up to 90 days of life) of purely human-based nutrition using mother's own milk (when available), donor milk preparations and a human-based fortifier (Prolact+4) as needed when compared with mother's own milk supplemented with pre-term formula and using a bovine-based HMF (as needed for fortification of mother's own milk), i.e. "Study Group 1"; or, when mother's milk is not available, comparing the use of donor milk (plus human milk based fortification) with pre-term/term formula, i.e. "Study Group 2". In both instances the comparison will be based on the primary endpoint of days of TPN, and on parameters such as time to full enteral feeding (approximately 150-160 mL/kg/day), amount of IV fluid support, culture-proven sepsis, NEC, death, growth and short-term development, cultured-proven sepsis and incidence of feeding intolerance in either a 2-arm (human nutrition versus bovine nutrition: "Study Group 2") or 3-arm randomized design (human fortifier given when feedings reach 40 mL/kg/day, human fortifier given when feedings reach 100 mL/kg/day, and bovine-based HMF given when feedings reach 100 mL/kg/day [or pre-term formula if mother's milk is not available]: "Study Group 1").
Statistically, the study will attempt to evaluate a null hypothesis of equivalent results with respect to these parameters between either the three types of fortifications in "Study Group 1" or the two types of overall nutrition in "Study Group 2", as compared with an alternative of some inequality between the groups, i.e. letting μ be the mean number of days of TPN any of the study arms, then for "Study Group 1 the hypotheses may be written as:
H0: μ control = μ human 40 = μhuman 100 and HA: At least two of μ control, μ human 40, and μhuman 100 are not equal, where "control" is the bovine-based HMF group, "human 40" is the human fortifier group starting at 40 mL/kg/day (arm 2) and "human 100" is the human fortifier group starting at 100 mL/kg/day (arm 1). For "Study Group 2", the competing hypotheses are: H0: μ formula = μ human and HA: μ formula ≠ μ human , where "formula" is the pre-term/term formula group and "human" is the human-based (donor milk/human-based fortifier) group.
In addition, data will be collected on overall survival and length of stay in the NICU. Any baby that does not complete the full study period will be right-censored in this regard for the purposes of data evaluation. For centers that obtain long-term follow up (18-24 months) on their patients, data on developmental outcomes will be evaluated as available.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Innsbruck, Austria, A-6020
- Innsbruck Children's Hospital
-
-
-
-
California
-
Berkeley, California, United States, 94705
- Alta Bates Summit Medical Center
-
San Diego, California, United States, 92103-8774
- University of California, San Diego Medical Center
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University School of Medicine
-
-
Florida
-
Gainesville, Florida, United States, 32610-0296
- Shands Children's Hospital
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush-Presbyterian St. Luke's Medical Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
-
New York
-
Manhasset, New York, United States, 11030
- Schneider Children's Hospital at North Shore
-
Rochester, New York, United States, 14642
- Strong Memorial Hospital
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Texas
-
Houston, Texas, United States, 77030
- Ben Taub Hospital/Baylor College of Medicine
-
San Antonio, Texas, United States, 78229-3900
- University of Texas Health Science Center
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Birth weight between 500 and 1250g.
- Have a reasonable expectation of survival for the maximum 90 day duration of the study.
- In "Study Group 1", must be able to adhere to a feeding protocol involving mother's own milk and that may include donor human milk with fortification using a human-based product (Prolact+4) or fortification with a bovine-based human milk fortifier and the use of a pre-term/term formula; or in "Study Group 2" the use of donor human milk with Prolact+4 or a pre-term/term formula from the time that the infant initiates enteral feeding through day 90 of life, until discharge from the study institution, discharge home, death or the initiation of at least 50% total oral nutrition (4 complete feeds in a 24 hour period), whichever comes first.
- Enteral feeding must begin before the 21st day of life.
- Total parenteral nutrition (TPN) initiated within 48 hours after birth.
- Informed consent obtained from parent or legal guardian.
Exclusion Criteria:
- Less than a reasonable expectation of survival for the infant's particular gestational age through the study period (first 90 days of life, discharge to a non-study institution, discharge home, death or initiation of 50% oral nutrition, whichever comes first).
- On any other clinical study affecting nutritional management during the study period.
- Decision to not start minimum enteral feed before day 21 of life.
- Decision to not start TPN within the first 48 hours after birth.
- Unable to obtain informed consent from parent or legal guardian prior to the initiation of enteral feeding.
- Presence of clinically significant congenital heart disease.
- Presence of any major congenital malformations.
- Reasonable potential for early transfer to a non-study institution.
- Unable to participate for any reason based on the decision of the study investigator.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1, arm 1
Human breast milk + Prolact20/Neo20 (as needed) + Prolact+4 (initiated when nutrition volume reaches 100 mL/kg/day, where Prolact20/Neo 20 are donor human milk formulations at 20 cal/oz, Prolact+4 is a human-milk derived human milk fortified designed to add 4 cal/oz to 20 cal/oz human breast milk.
|
Human milk fortifier is initiated when nutrition volume reaches 100 mL/kg/day
Other Names:
Human milk fortifier is initiated when nutrition volume reaches 40 mL/kg/day
Other Names:
Human milk fortifier initiated when nutrition volume reaches 100 mL/kg/day
Other Names:
|
Experimental: Group1, Arm 2
Human breast milk + Prolact20/Neo20 (as needed) + Prolact+4 (initiated when nutrition volume reaches 40 mL/kg/day), where Prolact20/Neo 20 are donor human milk formulations at 20 cal/oz, Prolact+4 is a human-milk derived human milk fortified designed to add 4 cal/oz to 20 cal/oz human breast milk.
|
Human milk fortifier is initiated when nutrition volume reaches 100 mL/kg/day
Other Names:
Human milk fortifier is initiated when nutrition volume reaches 40 mL/kg/day
Other Names:
Human milk fortifier initiated when nutrition volume reaches 100 mL/kg/day
Other Names:
|
Active Comparator: Group 1, Arm 3
Human breast milk + bovine-based human milk fortifier (initiated when nutrition volume reaches 100 mL/kg/day) + pre-term formula (as needed)
|
Bovine-based human milk fortifier is initiated when nutrition volume reaches 100 mL/kg/day
|
Experimental: Group 2, Arm 1
Prolact20/Neo20 + Prolact+4 (initiated when nutrition volume reaches 100 mL/kg/day), where Prolact20/Neo 20 are donor human milk formulations at 20 cal/oz, Prolact+4 is a human-milk derived human milk fortified designed to add 4 cal/oz to 20 cal/oz human breast milk.
|
Human milk fortifier is initiated when nutrition volume reaches 100 mL/kg/day
Other Names:
Human milk fortifier is initiated when nutrition volume reaches 40 mL/kg/day
Other Names:
Human milk fortifier initiated when nutrition volume reaches 100 mL/kg/day
Other Names:
|
Active Comparator: Group 2, Arm 2
Pre-term/term formula (minimum 20 cal/oz)
|
Bovine milk-derived nutrition formulated for very low birth weight infants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary measure of efficacy for the study is the number of days of TPN (total parenteral nutrition)
Time Frame: The first 90 days of life, discharge from the study institution or initiation of 50% oral nutrition (50% of the feeding volume in a given 24 hour period provided PO, or 4 complete PO feeds in a given 24 hour period), whichever comes first
|
The first 90 days of life, discharge from the study institution or initiation of 50% oral nutrition (50% of the feeding volume in a given 24 hour period provided PO, or 4 complete PO feeds in a given 24 hour period), whichever comes first
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Weight gain and other measures of growth including length and head circumference
Time Frame: The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
Daily amount of all nutrition
Time Frame: The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
Time to discharge from the NICU and hospital
Time Frame: The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
Frequency of occurrence of late-onset sepsis and necrotizing enterocolitis
Time Frame: The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
Frequency of feeding intolerance
Time Frame: The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
The first 90 days of life, transfer to non-study institution, or initiation of 50% oral feeding, whichever comes first
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Richard J Schanler, MD, Schneider Children's Hospital at North Shore
Publications and helpful links
General Publications
- Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawoger R, Kiechl-Kohlendorfer U, Chan GM, Blanco CL, Abrams S, Cotten CM, Laroia N, Ehrenkranz RA, Dudell G, Cristofalo EA, Meier P, Lee ML, Rechtman DJ, Lucas A. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010 Apr;156(4):562-7.e1. doi: 10.1016/j.jpeds.2009.10.040. Epub 2009 Dec 29.
- Cristofalo EA, Schanler RJ, Blanco CL, Sullivan S, Trawoeger R, Kiechl-Kohlendorfer U, Dudell G, Rechtman DJ, Lee ML, Lucas A, Abrams S. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013 Dec;163(6):1592-1595.e1. doi: 10.1016/j.jpeds.2013.07.011. Epub 2013 Aug 20.
- Ghandehari H, Lee ML, Rechtman DJ; H2MF Study Group. An exclusive human milk-based diet in extremely premature infants reduces the probability of remaining on total parenteral nutrition: a reanalysis of the data. BMC Res Notes. 2012 Apr 25;5:188. doi: 10.1186/1756-0500-5-188.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MPPF 001-2007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant, Very Low Birth Weight
-
Princess Amalia Children's ClinicCompleted
-
The Hospital for Sick ChildrenRecruitingVery Low Birth Weight InfantCanada
-
Children's Hospital of Fudan UniversityCompleted
-
Baylor College of MedicineRecruitingInfant, Very Low Birth WeightUnited States
-
Wyss Institute at Harvard UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
The Hospital for Sick ChildrenUniversity of Toronto; Sinai Health SystemCompletedInfant, Very Low Birth WeightCanada
-
Children's Hospital of Fudan UniversityCompleted
-
Children's Hospital of Fudan UniversityNot yet recruitingVery Low Birth Weight InfantChina
-
Baylor College of MedicineCompletedInfant, Very Low Birth WeightUnited States
-
Norwegian University of Science and TechnologyCompletedInfant, Very Low Birth WeightNorway
Clinical Trials on Pasteurized human milk and pasteurized human milk fortifier
-
Rennes University HospitalCompleted
-
National Center for Research Resources (NCRR)Baylor College of MedicineCompletedSepsis | Necrotizing EnterocolitisUnited States
-
Abbott NutritionCompleted
-
Augusta UniversityNeolac Inc dba Medolac LaboratoriesUnknownPremature Infant | Breast Milk ExpressionUnited States
-
Abbott NutritionCompleted
-
The University of Texas Health Science Center at...Baylor College of Medicine; Columbia University; University of Oklahoma; University... and other collaboratorsCompletedCongenital Heart DefectUnited States
-
NEOCOSURUnknown
-
Medical University of ViennaParacelsus Medical UniversityCompletedPreterm Infants | Weight Gain | Human Milk | Extremely Low Birth WeightAustria
-
NIZO Food ResearchFrieslandCampinaCompleted